CKD Bio Corp. (KRX:063160)

CKD Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 21, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	70,659	130,566	229,313	438,328	158,885	106,437
Market Cap Growth	-47.43%	-43.06%	-47.69%	175.88%	49.28%	68.02%
Enterprise Value	-	251,285	333,496	515,471	171,618	114,125
Last Close Price	12880.00	23691.32	41609.13	79343.05	29214.98	19440.71

Price Ratios

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 21, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
PE Ratio	-	-	-	70.61	12.95	13.38
Forward PE	-	20.10	20.10	30.19	10.95	-
PS Ratio	0.44	0.84	1.61	3.52	1.16	0.86
PB Ratio	0.54	0.88	1.42	2.60	1.00	0.72
P/TBV Ratio	0.56	0.91	1.45	2.64	1.01	0.73
P/OCF Ratio	-	-	-	90.86	9.35	6.85

EV Ratios

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 21, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
EV/Sales Ratio	-	1.61	2.35	4.14	1.25	0.92
EV/EBITDA Ratio	-	80.34	60.07	25.98	6.81	7.15
EV/EBIT Ratio	-	-	-	67.76	11.14	16.28

Financial Efficiency

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 21, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Debt / Equity Ratio	1.21	0.94	0.68	0.47	0.18	0.03
Debt / EBITDA Ratio	-	44.41	19.70	4.02	1.13	0.31
Net Debt / Equity Ratio	1.12	0.85	0.66	0.46	0.15	-0.08
Net Debt / EBITDA Ratio	-19.84	40.35	19.06	3.95	0.95	-0.74
Net Debt / FCF Ratio	-6.43	-13.42	-4.01	-1.38	-0.78	13.82
Asset Turnover	0.51	0.51	0.49	0.48	0.66	-
Inventory Turnover	2.04	1.87	1.99	2.14	3.38	-
Quick Ratio	0.65	0.49	0.76	0.58	1.06	2.03
Current Ratio	1.56	1.51	2.36	1.92	1.78	3.31
Return on Equity (ROE)	-16.26%	-10.80%	-3.98%	3.79%	8.01%	-
Return on Assets (ROA)	-4.96%	-3.03%	-2.46%	1.84%	4.61%	-
Return on Invested Capital (ROIC)	-9.07%	-5.47%	-4.45%	3.12%	7.60%	4.42%
Return on Capital Employed (ROCE)	-10.80%	-6.40%	-4.50%	3.20%	8.20%	4.40%

Yields

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 21, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Earnings Yield	-32.73%	-12.79%	-2.87%	1.42%	7.72%	7.47%
FCF Yield	-32.31%	-7.20%	-11.50%	-12.97%	-19.09%	-0.81%
Dividend Yield	-	-	0.24%	0.25%	0.65%	0.98%
Payout Ratio	-	-	-	16.53%	8.36%	25.79%
Buyback Yield / Dilution	0.02%	-	-1.40%	-0.46%	0.00%	0.03%
Total Shareholder Return	0.02%	-	-1.16%	-0.20%	0.65%	1.01%

Data Source: S&P Global Market Intelligence Last updated: Nov 14, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 21, 2026

Data Sources Report a data error